Scott Chapman

CEO at Carlin Consumer Health
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Atlanta Metropolitan Area

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Manufacturing
    • 1 - 100 Employee
    • CEO
      • Oct 2022 - Present

    • United States
    • Manufacturing
    • Managing Partner
      • Jan 2022 - Aug 2022

      The past created a path, a well-worn remnant of what’s been done before, that usually leads to the same results. We guide companies and brand teams to blaze new trails, helping them discover new opportunities to improve financial performance and accelerate value creation. The past created a path, a well-worn remnant of what’s been done before, that usually leads to the same results. We guide companies and brand teams to blaze new trails, helping them discover new opportunities to improve financial performance and accelerate value creation.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • General Manager, Advanced Vision Research and SVP, Akorn Inc.
      • 2012 - Jul 2021

      Responsible for leading the Akorn consumer health business, Advanced Vision Research. Built a high-performance team and trusted business partner relationships to successfully build a portfolio of leading consumer health brands, including TheraTears. Led significant value creation, culminating in the sale of the division for $230 million. Responsible for leading the Akorn consumer health business, Advanced Vision Research. Built a high-performance team and trusted business partner relationships to successfully build a portfolio of leading consumer health brands, including TheraTears. Led significant value creation, culminating in the sale of the division for $230 million.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Executive Director, U.S. OTC Marketing
      • 2007 - 2011

      Led the turnaround of the OTC consumer eye drop and nutritional supplement business in the U.S., while B+L was owned by private equity firm Warburg Pincus. Transform a portfolio of tired brands into a core business unit with great brands and rapidly growing sales and earnings. Led the turnaround of the OTC consumer eye drop and nutritional supplement business in the U.S., while B+L was owned by private equity firm Warburg Pincus. Transform a portfolio of tired brands into a core business unit with great brands and rapidly growing sales and earnings.

    • United States
    • Biotechnology Research
    • 300 - 400 Employee
    • Vice President Global Marketing
      • 2005 - 2007

Education

  • The Wharton School
    Executive Education
  • SMU Cox School of Business
    Master of Business Administration - MBA
  • International University of Japan
  • Ball State University - Miller College of Business
    Bachelor of Science - BS

Community

You need to have a working account to view this content. Click here to join now